Teladoc Health (NYSE:TDOC) PT Lowered to $17.00

Teladoc Health (NYSE:TDOC) had its price objective cut by Canaccord Genuity Group from $25.00 to $17.00 in a report issued on Thursday morning, Benzinga reports. They currently have a buy rating on the health services provider’s stock.

Other research analysts have also issued research reports about the company. Barclays dropped their price objective on Teladoc Health from $25.00 to $20.00 and set an overweight rating on the stock in a report on Friday, April 26th. Needham & Company LLC reaffirmed a hold rating on shares of Teladoc Health in a research note on Friday, April 26th. Wells Fargo & Company reduced their price objective on shares of Teladoc Health from $17.00 to $15.00 and set an equal weight rating for the company in a research note on Monday, April 29th. Royal Bank of Canada decreased their price objective on shares of Teladoc Health from $25.00 to $18.00 and set an outperform rating on the stock in a report on Friday, April 26th. Finally, TD Cowen dropped their target price on shares of Teladoc Health from $16.00 to $15.00 and set a hold rating for the company in a report on Friday, April 26th. Thirteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of Hold and a consensus price target of $14.72.

Teladoc Health Stock Performance

TDOC traded down $0.64 during trading on Thursday, reaching $7.95. The company’s stock had a trading volume of 1,804,713 shares, compared to its average volume of 5,411,787. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. The company’s fifty day moving average price is $10.01 and its 200-day moving average price is $13.82. Teladoc Health has a 52-week low of $7.93 and a 52-week high of $26.67. The company has a market capitalization of $1.35 billion, a price-to-earnings ratio of -5.82 and a beta of 0.94.

Insiders Place Their Bets

In other Teladoc Health news, Director Karen L. Daniel sold 9,834 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total value of $117,024.60. Following the completion of the sale, the director now directly owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 15,388 shares of company stock valued at $178,225 in the last ninety days. Insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently made changes to their positions in TDOC. Vanguard Group Inc. lifted its position in Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after buying an additional 1,855,480 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Teladoc Health by 25.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider’s stock valued at $82,636,000 after acquiring an additional 767,999 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Teladoc Health by 6.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,654,116 shares of the health services provider’s stock worth $35,646,000 after acquiring an additional 104,531 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Teladoc Health by 1.7% in the second quarter. Bank of New York Mellon Corp now owns 916,129 shares of the health services provider’s stock worth $8,960,000 after acquiring an additional 14,910 shares during the last quarter. Finally, Allianz Asset Management GmbH grew its holdings in Teladoc Health by 15.4% in the fourth quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock valued at $13,021,000 after purchasing an additional 80,805 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.